Information Provided By: 
Fly News Breaks for June 3, 2015
AMGN
Jun 3, 2015 | 07:36 EDT
Piper Jaffray analyst Joshua Schimmer calls Amgen "the quiet ASCO winner" and reiterates an Overweight rating on the name with a $192 price target. Schimmer believes antibodies remain under the radar and that Amgen's ability to build off the MicroMet acquisition and improve durability of the constructs gives it an attractive position in the field.
News For AMGN From the Last 2 Days
There are no results for your query AMGN
